Diabetes mellitus is also known as diabetes, is a cluster of metabolic disorders which escalates the high blood sugar level for long period. This disorder can lead to serious health problems such as (stroke, heart disease, even death) if it is properly diagnosed. There are four main types of diabetes such as type 1, type 2, type 3 and gestational diabetes. The diagnosis of the diabetes depend on the type of diabetes. For instance, random blood sugar test, glycated hemoglobin test, fasting blood sugar test, are the common tests for diabetes 1 and diabetes 2 whereas initial glucose challenge test can be recommended for gestational diabetes. However, genetic testing is an innovative approach for diagnosis of diabetes which determines the changes in chromosomes, proteins and genes. In this test, human saliva is screened for diabetes- this test won’t confirm whether someone has diabetes but this test provides several information whether someone is at the risk of becoming diabetic.

According to the World Health Organization (WHO), the number of people had grown by 4.1% since last five years. The global genetic testing market for diabetes is primarily driven by the rise in cases of diabetes across worldwide, diagnosis and treatment rate. Conversely, the growth of the global genetic testing market for diabetes may be hampered by the limited awareness about the genetic testing and less adoption of genetic testing for diagnosis of diabetes in the upcoming future. On the other hand, increasing research and development expenditure by the major companies, strategic alliance among the major companies, technological advancement, ongoing research etc. will provide the global genetic testing market for diabetes an opportunity to propel during the forecast period.

The global genetic testing market for diabetes can be classified into type of diabetes and end user. In terms of type of diabetes, the global genetic testing market for diabetes can be segmented into type 1 diabetes, type 2 diabetes and others. Type 2 diabetes segment was estimated to capture the maximum market share in the global genetic testing market for diabetes in 2017 followed by type 1 diabetes segment. By end-user, the global genetic testing market for diabetes can be classified into hospitals, independent clinics and others (academic and research organizations and household settings). The hospitals segment hold the major market share in the global genetic testing for diabetes in 2017, owing to the wide availabilities of the genetic testing panels in the hospitals, presence of skilled professionals etc.

Geographically, the global genetic testing market for diabetes can be classified into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. According to the CDC, more than 100 million of American adults have been suffering from diabetes or pre-diabetes (10% of the American adults is confirmed cases of diabetes). The genetic testing market for diabetes in North America hold the maximum market share in 2017, owing to significant number of diabetic population, high rate of diagnosis and treatment of diabetes, strong medical infrastructure. In Europe, Germany, France, and the U.K. accounted for major share of the genetic testing market for diabetes market in 2017, while the market in Italy and Spain is expected to witness significant growth during the forecast period. Highly developed health care industry, high rate of diagnosis and treatment of diabetes, string research and development, and participation of small companies in the market are the key factors which supported Germany, France, and the U.K. to capture the leading share of the genetic testing market for diabetes in Europe in 2017.

In Asia Pacific, China and Japan held the dominant share of the genetic testing market for diabetes market in 2017. The genetic testing market for diabetes in India is estimated to grow at a significant CAGR in the near future, owing to high population, the developing healthcare industry, and presence of well-established domestic players. Underdeveloped healthcare infrastructure is likely to hamper the growth of the genetic testing market for diabetes in Latin America and Middle East & Africa during the forecast period.

Key companies involved in the global genetic testing market for diabetes are 23andMe, deCODE genetics, Negen and others

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Diabetes Genetic Testing Market

Pre Book